Tharimmune Inc (THAR)
0.3701
0.00 (0.00%)
USD |
NASDAQ |
May 20, 13:37
Tharimmune Total Liabilities (Quarterly): 1.838M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.838M |
| December 31, 2023 | 1.815M |
| September 30, 2023 | 1.41M |
| June 30, 2023 | 1.530M |
| March 31, 2023 | 1.521M |
| December 31, 2022 | 1.145M |
| September 30, 2022 | 0.7167M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.7455M |
| March 31, 2022 | 1.016M |
| December 31, 2021 | 5.307M |
| September 30, 2021 | 7.560M |
| June 30, 2021 | 6.579M |
| December 31, 2020 | 4.012M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7167M
Minimum
Sep 2022
7.560M
Maximum
Sep 2021
2.707M
Average
1.530M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | 769.34M |
| Mirum Pharmaceuticals Inc | 417.36M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.887M |
| Shareholders Equity (Quarterly) | 7.049M |